NPI registry status
Active
2026 NPPES data Psychiatric/Mental Health Nurse Practitioner NPI 1295495588
Verify on CMS → Temitope Agunbiade
Psychiatric/Mental Health Nurse Practitioner in Monroe, New Jersey.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 40,776 in Psychiatric/Mental Health Nurse Practitioner, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
2K
Medicare Part D claims · 185 beneficiaries · Psychiatric/Mental Health Nurse Practitioner avg: 927
Generic prescribing
97%
generic claims · 3% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
75/100
▼ 8 pts below national avg 83.1 · Above neutral
Industry payments
$105.5
5 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2023
Compiled from official public sources by the PlainDoctor editorial team.
What the federal data shows
Temitope Agunbiade reported a CMS MIPS final score of 75/100 - below the 83.1 national average - and filed 1,559 Medicare Part D claims in 2023.
- 75/100
- MIPS score · -8 vs avg
- 2K
- Part D claims, 2023
- 97%
- generic prescribing
- $105.5
- industry payments (Sunshine Act)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Temitope Agunbiade's MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
75 15th percentile higher than 15% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Temitope Agunbiade sits
This provider among psychiatric/mental health nurse practitioner peers
Across the 1,917 psychiatric/mental health nurse practitioner providers who report both Medicare Part D prescribing and a MIPS quality score, Temitope Agunbiade writes more Part D claims than 72% of them and scores higher on MIPS quality than 12% - placing this provider in the high-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one psychiatric/mental health nurse practitioner peer from a representative sample of 60; the gold marker is Temitope Agunbiade. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
What does the federal data show about Temitope Agunbiade?
Below national averagePrimary specialty
Psychiatric/Mental Health Nurse Practitioner
Medicare Part D claims
1,559 68% vs specialty avg
MIPS final score
75/100 8.1 pts vs avg
Specialty distribution in New Jersey
How Psychiatric/Mental Health Nurse Practitioner compares to other specialties among New Jersey providers
Medicare quality performance, MIPS
Temitope Agunbiade's 2023 MIPS final score plotted against the Psychiatric/Mental Health Nurse Practitioner national average
- MIPS Final Score
- 75/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Psychiatric/Mental Health Nurse Practitioner) - 75/100 vs national avg 83.1
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Temitope Agunbiade appears in the CMS NPPES registry as a Psychiatric/Mental Health Nurse Practitioner provider at 14 CRESTWOOD CT, Monroe, NJ, 08831, with a listed phone of (732) 586-7387. NPI 1295495588 was issued on 12/28/2021.
Medicare Part D records for calendar year 2023 show 1,559 prescription claims written by this provider, covering 185 Medicare beneficiaries and totaling roughly $46K in drug spend, split 3% brand-name and 97% generic by claim count. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 75/100 for the 2023 performance year, compared with the national average of 83.1.
Psychiatric/Mental Health Nurse Practitioner is a mid-sized specialty nationwide, with 40,776 enrolled providers across 54 states and an average of 927 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1295495588 |
|---|---|
| Specialty | Psychiatric/Mental Health Nurse Practitioner |
| Gender | Female |
| NPI Issued | 12/28/2021 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
75
Final Score
Avg: 83.1
Reporting: Group practice
Hospital and facility affiliations
Facilities where Temitope Agunbiade bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Barnabas Health Medical Group, PC
Somerville, NJ
NJ Memory And Behavioral Care
Cedar Knolls, NJ
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Temitope Agunbiade. Source: openpaymentsdata.cms.gov.
Total received
$106
Largest payer
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Generic-heavy
Temitope Agunbiade - brand share 3.0%
Psychiatric/Mental Health Nurse Practitioner average
3% brand-name claims vs 97% generic, on 1,559 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
1,559
Total Claims
$46K
Total Drug Cost
185
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 1,615
- Total Day Supply
- 43,601
- Brand vs Generic
- 3% brand / 97% generic
- Brand Drug Cost
- $10K
- Generic Drug Cost
- $36K
Patient Demographics
- Average Patient Age
- 81.0 years
- Avg HCC Risk Score
- 2.34
- Gender Split
- 79% female / 21% male
- Age Distribution
- <65: 14, 65-74: 34, 75-84: 56, 85+: 81
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Temitope Agunbiade prescribes most
Top Medicare Part D drugs by claim count, 2023
- Divalproex Sodium
Divalproex Sodium
193 claims
- Sertraline Hcl
Sertraline Hcl
169 claims
- Mirtazapine
Mirtazapine
142 claims
- Escitalopram Oxalate
Escitalopram Oxalate
110 claims
- Paroxetine Hcl
Paroxetine Hcl
96 claims
- Risperidone
Risperidone
95 claims
- Quetiapine Fumarate
Quetiapine Fumarate
93 claims
- Alprazolam
Alprazolam
81 claims
| Drug | Claims |
|---|---|
| Divalproex Sodium | 193 |
| Sertraline Hcl | 169 |
| Mirtazapine | 142 |
| Escitalopram Oxalate | 110 |
| Paroxetine Hcl | 96 |
| Risperidone | 95 |
| Quetiapine Fumarate | 93 |
| Alprazolam | 81 |
| Trazodone Hcl | 81 |
| Olanzapine | 76 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
More Psychiatric/Mental Health Nurse Practitioner in NJ →
All providers in New Jersey →
Compare specialties →
Psychiatric/Mental Health Nurse Practitioner Overview
How Temitope Agunbiade fits within the Psychiatric/Mental Health Nurse Practitioner landscape nationally.
40,776
Psychiatric/Mental Health Nurse Practitioner Providers in US
54
States with Psychiatric/Mental Health Nurse Practitioner
927
Avg Claims per Provider
Temitope Agunbiade's 1,559 claims are above the specialty average of 927.
Nearby Psychiatric/Mental Health Nurse Practitioner Providers in New Jersey
Other clinicians with the same primary specialty enrolled in New Jersey, drawn from the same CMS NPPES roster as Agunbiade.
Dr. Ugochi Abazie
DNP, APN, PMHNP-BC
Roselle, NJ
Dr. Kimberly Abbaticola
MSN, APRN, PMHNP-BC
Howell, NJ
Dr. Salman Abouzied
PMH-NP
Newark, NJ
Mary Abue
Linden, NJ
Fathia Abusheraiah
Paterson, NJ
Compare Psychiatric/Mental Health Nurse Practitioner nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the New Jersey medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Psychiatric/Mental Health Nurse Practitioner peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore New Jersey
Frequently Asked Questions
What is Temitope Agunbiade's specialty? ▼
Temitope Agunbiade specializes in Psychiatric/Mental Health Nurse Practitioner and practices in Monroe, New Jersey.
How much does Temitope Agunbiade prescribe under Medicare Part D? ▼
In 2023, Temitope Agunbiade wrote 1,559 Medicare Part D claims totaling $46K in drug costs for 185 beneficiaries.
What is Temitope Agunbiade's Medicare quality score? ▼
Temitope Agunbiade has a CMS MIPS Final Score of 75/100. The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Temitope Agunbiade located? ▼
Temitope Agunbiade is located at 14 CRESTWOOD CT, Monroe, NJ, 08831. Phone: (732) 586-7387.
What is Temitope Agunbiade's NPI number? ▼
Temitope Agunbiade's National Provider Identifier (NPI) is 1295495588, issued on 12/28/2021.
Does Temitope Agunbiade prescribe more brand-name or generic drugs? ▼
Temitope Agunbiade's prescribing is 3% brand-name and 97% generic drugs by claim count, with $10K in brand drug costs.
How many Psychiatric/Mental Health Nurse Practitioner providers are there in the US? ▼
There are 40,776 Psychiatric/Mental Health Nurse Practitioner providers across 54 states in the US. The average Psychiatric/Mental Health Nurse Practitioner provider writes 927 Medicare Part D claims per year.
What drugs does Temitope Agunbiade prescribe most often? ▼
Based on 2023 Medicare Part D data, Temitope Agunbiade's most frequently prescribed drugs include Divalproex Sodium, Sertraline Hcl, Mirtazapine. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Temitope Agunbiade accept Medicare? ▼
Temitope Agunbiade appears in CMS Medicare data with 1,559 Part D claims and 185 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Temitope Agunbiade's credentials? ▼
Temitope Agunbiade's NPI is 1295495588. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Compiled from official public sources by the PlainDoctor editorial team.